Skip to main content
Noma survivors: closer to getting the attention they deserve

Neglected diseases

Neglected diseases disproportionally affect people in the world’s least-developed countries and there are few tools available with which to diagnose and treat.

They cover neglected tropical diseases, such as kala azar (visceral leishmaniasis) and sleeping sickness (human African trypanosomiasis), plus issues such as snakebite envenoming, but also Chagas, noma, cutaneous leishmaniasis, and others.

These diseases are considered ‘neglected’, as – although they are usually life-threatening and claim thousands of lives every year – the pharmaceutical and diagnostic industries ignore the development of vaccines, diagnostic tools and drugs to tackle them.

Neglected diseases

 
Neglected diseases

Reflection and Reaction: Drugs for neglected diseases

Project Update 27 Jul 2002
 
Neglected diseases

The Lancet: Drugs for neglected diseases

Project Update 1 Jul 2002
 
Neglected diseases

Drugs for neglected diseases

Project Update 21 Jun 2002
 
Neglected diseases

MSF 'Trapped' trailers crossing Europe and North America

Campaign 18 Jun 2002
 
DNDi

DND Conference review

Project Update 8 Apr 2002
 
Neglected diseases

Public sector must develop drugs for neglected diseases

Project Update 23 Mar 2002
Advanced HIV management in Homa Bay
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site